ArticleNPJ breast cancer2019

Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models.

Ana S Leal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.